20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.
Seven big projects with international pharmaceutical companies were completed. Two research papers co-authored with colleagues from other organizations were published in PLOS Computational Biology and CPT: Pharmacometrics & Systems Pharmacology.
ISBM took part in 2 exhibitions and 4 important conferences, the employees presented their reports and posters on The International Liver Congress 2016, Population Approach Group in Europe 2016 Meeting (PAGE 2016), American Society for Clinical Pharmacology and Therapeutics 2016 Meeting (ASCPT 2016) and 6th American Conference on Pharmacometrics (ACoP6). And ISBM CEO, Oleg Demin, won the Quality Award for his oral presentation at the ACoP6.
We released an updated version of the Immune Response Template (IRT), a platform for Quantitative Systems Pharmacology modeling in the immune oncology field. It’s a big step for further QSP platform solutions development.
A new working year starts from the very important event – ASCPT 2017 Meeting. ISBM presents 8 posters and the IRT stand at the Exhibition. We will write about it in more details soon.
| ← | February 2017 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
1.
02 Feb 2017 15:38
ISBM releases the updated version of Immune Response Template
Moscow, Russia - February 2, 2017. Institute for Systems Biology Moscow (ISBM) announced the recent update of the Immune Response Template (IRT) platform and its online demo. The project aimed to integrate and visualize available data on immune cells, cytokine, chemokines and other mediators interactions in human. IRT is a unique tool due to its focus on quantitative systems pharmacology (QSP) modeling. Using the platform modelers in pharmaceutical companies can strongly improve the drug R&D process.
|
3
|
4
|
5
| ||
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
|
27
|
28
| |||||
Thank you for your message! We will get back to you shortly.
